Compared with NSCLC tumor tissues, the pooled sensitivity and specificity of cfDNA for the detection of EGFR mutation status were 0.60 (95% confidence intervals (95% CI) = 0.57–0.62) and 0.94 (95% CI = 0.93–0.95), respectively. This evidence concerns the gene EGFR and non-small cell lung carcinoma.